跳至主要内容
临床试验/EUCTR2019-001941-41-IT
EUCTR2019-001941-41-IT进行中(未招募)1 期

Shortened antibiotic therapy for febrile urinary tract infections (UTI) in childhood: a multicentre randomized controlled trial - Short UTI

IRCCS MATERNO INFANTILE BURLO GAROFOLO0 个研究点目标入组 520 人开始时间: 2021年5月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
520

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - age from 3 months to 5 years
  • - clinical diagnosis of febrile urinary tract infection, defined by fever > or = 38 °C and positive result of urinalysis (nitrite and/or leukocyte esterase positivity) in two consecutive urine samples collected by bladder catheterization or clan catch
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Complicated febrile urinary tract infection (septic appearance, repeated vomiting with the impossibility to take the antibiotic by mouth, moderate severe-dehydration with the need for intravenous antibiotic therapy)
  • - Presence of an inserted urinary catheter
  • - Immunodeficiency
  • - Hypersensitivity to the active substance or other beta-lactam antibiotics
  • - Any Antibiotic treatment received in the previous 15 days.
  • - Presence of other chronic, uncontrolled medical condition
  • - Neurological bladder
  • - Phenylketonuria or glucose-galactose malabsorption
  • - Intestinal malabsorption
  • - Need for hospitalization
  • - poor compliance.

研究者

发起方
IRCCS MATERNO INFANTILE BURLO GAROFOLO

相似试验

Shortened antibiotic therapy in urinary tract... | 临床试验